<DOC>
	<DOC>NCT02323997</DOC>
	<brief_summary>This study will investigate the types of HPV in samples from women with cervical pre-cancer and cancer and gather information to help investigate the impact of HPV vaccination in Switzerland.</brief_summary>
	<brief_title>Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Participant is willing and able to give informed consent for participation in the study. Participant is literate in German, French, Italian or English. Female, aged 18 years or above. Histologically confirmed CIN3+ lesions, i.e. CIN3, adenocarcinoma in situ and invasive carcinoma of the cervix. Participant resides in the canton Zurich, Geneva, Basel, Baselland, Luzern or Ticino.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HPV</keyword>
	<keyword>cervical cancer</keyword>
	<keyword>human papillomavirus</keyword>
	<keyword>cervical pre-cancer</keyword>
	<keyword>cervical neoplasia</keyword>
</DOC>